471 related articles for article (PubMed ID: 31219077)
1. Efflux pump inhibitors for bacterial pathogens: From bench to bedside.
Sharma A; Gupta VK; Pathania R
Indian J Med Res; 2019 Feb; 149(2):129-145. PubMed ID: 31219077
[TBL] [Abstract][Full Text] [Related]
2. Efflux pump inhibitors: new updates.
AlMatar M; Albarri O; Makky EA; Köksal F
Pharmacol Rep; 2021 Feb; 73(1):1-16. PubMed ID: 32946075
[TBL] [Abstract][Full Text] [Related]
3. Bacterial efflux pumps involved in multidrug resistance and their inhibitors: rejuvinating the antimicrobial chemotherapy.
Bhardwaj AK; Mohanty P
Recent Pat Antiinfect Drug Discov; 2012 Apr; 7(1):73-89. PubMed ID: 22353004
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of multidrug resistant efflux systems in bacteria.
Zechini B; Versace I
Recent Pat Antiinfect Drug Discov; 2009 Jan; 4(1):37-50. PubMed ID: 19149695
[TBL] [Abstract][Full Text] [Related]
5. Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria.
Wang Y; Venter H; Ma S
Curr Drug Targets; 2016; 17(6):702-19. PubMed ID: 26424403
[TBL] [Abstract][Full Text] [Related]
6. Computational approaches in efflux pump inhibitors: current status and prospects.
Rathi E; Kumar A; Kini SG
Drug Discov Today; 2020 Oct; 25(10):1883-1890. PubMed ID: 32712312
[TBL] [Abstract][Full Text] [Related]
7. Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux Pumps.
Mahmood HY; Jamshidi S; Sutton JM; Rahman KM
Curr Med Chem; 2016; 23(10):1062-81. PubMed ID: 26947776
[TBL] [Abstract][Full Text] [Related]
8. Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.
Schweizer HP
Expert Opin Drug Discov; 2012 Jul; 7(7):633-42. PubMed ID: 22607346
[TBL] [Abstract][Full Text] [Related]
9. Efflux pumps in multidrug-resistant Acinetobacter baumannii: Current status and challenges in the discovery of efflux pumps inhibitors.
Verma P; Tiwari M; Tiwari V
Microb Pathog; 2021 Mar; 152():104766. PubMed ID: 33545327
[TBL] [Abstract][Full Text] [Related]
10. Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump.
Abdali N; Parks JM; Haynes KM; Chaney JL; Green AT; Wolloscheck D; Walker JK; Rybenkov VV; Baudry J; Smith JC; Zgurskaya HI
ACS Infect Dis; 2017 Jan; 3(1):89-98. PubMed ID: 27768847
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy.
Mahamoud A; Chevalier J; Alibert-Franco S; Kern WV; Pagès JM
J Antimicrob Chemother; 2007 Jun; 59(6):1223-9. PubMed ID: 17229832
[TBL] [Abstract][Full Text] [Related]
12. Efflux pump inhibitors of clinically relevant multidrug resistant bacteria.
Lamut A; Peterlin Mašič L; Kikelj D; Tomašič T
Med Res Rev; 2019 Nov; 39(6):2460-2504. PubMed ID: 31004360
[TBL] [Abstract][Full Text] [Related]
13. The development of efflux pump inhibitors to treat Gram-negative infections.
Blanco P; Sanz-García F; Hernando-Amado S; Martínez JL; Alcalde-Rico M
Expert Opin Drug Discov; 2018 Oct; 13(10):919-931. PubMed ID: 30198793
[TBL] [Abstract][Full Text] [Related]
14. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.
Piddock LJ
Clin Microbiol Rev; 2006 Apr; 19(2):382-402. PubMed ID: 16614254
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.
Wieczorek P; Sacha P; Hauschild T; Zórawski M; Krawczyk M; Tryniszewska E
Folia Histochem Cytobiol; 2008; 46(3):257-67. PubMed ID: 19056528
[TBL] [Abstract][Full Text] [Related]
16. Next-generation strategy for treating drug resistant bacteria: Antibiotic hybrids.
Gupta V; Datta P
Indian J Med Res; 2019 Feb; 149(2):97-106. PubMed ID: 31219074
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux.
Van Bambeke F; Pagès JM; Lee VJ
Recent Pat Antiinfect Drug Discov; 2006 Jun; 1(2):157-75. PubMed ID: 18221142
[TBL] [Abstract][Full Text] [Related]
18. The Role of Essential Oils in the Inhibition of Efflux Pumps and Reversion of Bacterial Resistance to Antimicrobials.
Agreles MAA; Cavalcanti IDL; Cavalcanti IMF
Curr Microbiol; 2021 Oct; 78(10):3609-3619. PubMed ID: 34432112
[TBL] [Abstract][Full Text] [Related]
19. [The importance of efflux systems in antibiotic resistance and efflux pump inhibitors in the management of resistance].
Aygül A
Mikrobiyol Bul; 2015 Apr; 49(2):278-91. PubMed ID: 26167829
[TBL] [Abstract][Full Text] [Related]
20. Efflux pumps of gram-negative bacteria, a new target for new molecules.
Pagès JM; Sandrine AF; Mahamoud A; Bolla JM; Davin-Regli A; Chevalier J; Garnotel E
Curr Top Med Chem; 2010; 10(18):1848-57. PubMed ID: 20615189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
